Postpolio syndrome
Chapter 6:Diseases of the nervous system
ICD-10 G14 is a billable code used to indicate a diagnosis of postpolio syndrome.
Postpolio syndrome (PPS) is a condition that affects polio survivors, typically occurring 15 to 40 years after recovery from an initial acute polio infection. It is characterized by new muscle weakness, fatigue, pain, and atrophy in previously affected muscles, as well as in muscles that were never affected by the virus. The exact cause of PPS is not fully understood, but it is believed to be related to the gradual degeneration of motor neurons that were previously damaged during the initial polio infection. This syndrome can significantly impact the quality of life, leading to difficulties in mobility and daily activities. Symptoms may also include sleep disturbances, cold intolerance, and cognitive changes. Diagnosis is primarily clinical, based on the history of polio and the emergence of new symptoms. Management focuses on symptomatic relief and rehabilitation, including physical therapy and lifestyle modifications to enhance function and quality of life.
Detailed history of polio infection, current symptoms, and neurological examination findings.
Patients presenting with new muscle weakness or fatigue years after polio recovery.
Neurologists should ensure clear documentation of symptom onset and progression to support the diagnosis of PPS.
Assessment of functional status, rehabilitation goals, and treatment plans.
Patients requiring physical therapy for muscle weakness and mobility issues.
Rehabilitation specialists should document the impact of PPS on daily activities and quality of life.
Used for assessing functional limitations in patients with PPS.
Detailed evaluation of physical function and treatment goals.
Physical therapists should document the impact of PPS on mobility and daily activities.
The primary symptom of postpolio syndrome is new muscle weakness, which can occur in muscles previously affected by polio as well as those that were not.
